TRTME: Improving Outpatient Initiation of Medication for Opioid Use Disorder Following Hospitalization
Public ClinicalTrials.gov record NCT07780097. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Pilot Randomized Controlled Trial to Improve Outpatient Initiation of Medication for Opioid Use Disorder (MOUD) Following Hospitalization: The TRTME (Tailored Overdose Risk Feedback, Testimonials for MOUD Treatment, and Education on MOUD and Opioid Overdose) Trial
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to evaluate the ability of TRTME to increase initiation of MOUD outpatient treatment and MOUD knowledge in hospitalized patients with OUD deemed to be good candidates for MOUD by the UCMC Addiction Consult Team (ACT). The secondary objective is to evaluate the ability of TRTME to decrease stigma and increase drug self-efficacy.
Study identification
- NCT ID
- NCT07780097
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 30 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 11, 2026
- Primary completion
- Feb 27, 2027
- Completion
- Feb 27, 2027
- Last update posted
- Aug 20, 2026
2026 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Cincinnati Addiction Sciences Division | Cincinnati | Ohio | 45229 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Opioid Use Disorder trials
Other public records listing Opioid Use Disorder. Sorted by last update posted; newest first. Not a recommendation.
- NCT07795840: The ConCERN Intervention for Loved Ones of Those With Opioid Use Disorder Not yet recruiting
- NCT07787039: Supporting Treatment for Opioids and Recovery Capital (STORC) - R61 Phase Not yet recruiting
- NCT07778394: Personalized Addiction Treatment eHancement Recruiting
- NCT07610746: Cerebral Physiology of NOWS Recruiting
- NCT07770555: Deep Transcranial Magnetic Stimulation for Tobacco Cessation in Adults With Opioid Use Disorder Not yet recruiting
- NCT06367387: Pain Self-Management and Patient-Oriented Dosing for Pain and in Retention Opioid Treatment Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07780097, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 20, 2026 · Synced Aug 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07780097 live on ClinicalTrials.gov.